US To Approve AstraZeneca-Oxford COVID-19 Vaccine
United States is expected to approve low-cost AstraZeneca/Oxford COVID-19 vaccine in April, a senior official said, more than three months after Britain’s green light on Wednesday.
Moncef Slaoui, chief advisor to Operation Warp Speed,…